These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 18312903

  • 1. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA, Gheorghiade M.
    Cardiol Clin; 2008 Feb; 26(1):23-40, vi. PubMed ID: 18312903
    [Abstract] [Full Text] [Related]

  • 2. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA, Gheorghiade M.
    Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
    [No Abstract] [Full Text] [Related]

  • 3. Traditional and novel approaches to management of heart failure: successes and failures.
    Anand IS, Florea VG.
    Cardiol Clin; 2008 Feb; 26(1):59-72, vi. PubMed ID: 18312906
    [Abstract] [Full Text] [Related]

  • 4. Management of diastolic heart failure.
    le Jemtel TH, Talreja A.
    Rev Cardiovasc Med; 2004 Feb; 5 Suppl 4():S37-44. PubMed ID: 15627918
    [Abstract] [Full Text] [Related]

  • 5. Rationale and design of a randomized trial to assess the effects of beta-blocker in diastolic heart failure; Japanese Diastolic Heart Failure Study (J-DHF).
    Hori M, Kitabatake A, Tsutsui H, Okamoto H, Shirato K, Nagai R, Izumi T, Yokoyama H, Yasumura Y, Ishida Y, Matsuzaki M, Oki T, Sekiya M, J-DHF Program Committee.
    J Card Fail; 2005 Sep; 11(7):542-7. PubMed ID: 16198251
    [Abstract] [Full Text] [Related]

  • 6. Treatment of heart failure with preserved systolic function.
    de Groote P, Herpin D, Diévart F, Hanon O, Trochu JN, Artigou JY, Galinier M, Habib G, Juillière Y, Neuder Y, Roudaut R, Komajda M.
    Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
    [Abstract] [Full Text] [Related]

  • 7. Implications of heart failure drug trials: COMET, CHARM, EPHESUS.
    Hiestand B, Abraham WT.
    Rev Cardiovasc Med; 2005 May; 6 Suppl 2():S4-11. PubMed ID: 15891699
    [Abstract] [Full Text] [Related]

  • 8. Diastolic heart failure: state of the science on best treatment practices.
    Reddersen LA, Keen C, Nasir L, Berry D.
    J Am Acad Nurse Pract; 2008 Oct; 20(10):506-14. PubMed ID: 19128346
    [Abstract] [Full Text] [Related]

  • 9. [Hyperkalemia, heart failure and reduced renal function].
    Bugge JF.
    Tidsskr Nor Laegeforen; 2010 Jul 01; 130(13):1354-5. PubMed ID: 20596118
    [No Abstract] [Full Text] [Related]

  • 10. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
    O'Connor CM, Arumugham P.
    Clin Geriatr Med; 2007 Feb 01; 23(1):141-53. PubMed ID: 17126759
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of heart failure and preserved systolic function].
    Dahlström U, Boman K, Brodin LA, Hagerman I, Willenheimer R.
    Lakartidningen; 2007 Feb 01; 104(34):2348-50. PubMed ID: 17907560
    [No Abstract] [Full Text] [Related]

  • 12. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G, Di Lenarda A, Metra M, Nodari S, Moretti M, Brentana L, Dei Cas L, Sinagra G.
    Ital Heart J; 2004 Dec 01; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [Abstract] [Full Text] [Related]

  • 13. Acute decompensated heart failure: best evidence and current practice.
    Mehta R, Feldman D.
    Minerva Cardioangiol; 2005 Dec 01; 53(6):537-47. PubMed ID: 16333237
    [Abstract] [Full Text] [Related]

  • 14. [Hypotension associated with heart failure].
    Fujita H.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():375-82. PubMed ID: 17571409
    [No Abstract] [Full Text] [Related]

  • 15. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S.
    Kyobu Geka; 2007 Jun 28; 60(6):484-7. PubMed ID: 17564066
    [Abstract] [Full Text] [Related]

  • 16. Neurohormones and heart failure: the importance of aldosterone.
    Odedra K, Ferro A.
    Int J Clin Pract; 2006 Jul 28; 60(7):835-46. PubMed ID: 16846401
    [Abstract] [Full Text] [Related]

  • 17. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.
    Howard PA, Cheng JW, Crouch MA, Colucci VJ, Kalus JS, Spinler SA, Munger M.
    Ann Pharmacother; 2006 Sep 28; 40(9):1607-17. PubMed ID: 16896019
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic management of heart failure caused by systolic dysfunction.
    Chavey WE, Bleske BE, Van Harrison R, Hogikyan RV, Kesterson SK, Nicklas JM.
    Am Fam Physician; 2008 Apr 01; 77(7):957-64. PubMed ID: 18441861
    [Abstract] [Full Text] [Related]

  • 19. Neurohormonal antagonism in heart failure: what is the optimal strategy?
    Sackner-Bernstein JD, Hart D.
    Mt Sinai J Med; 2004 Mar 01; 71(2):115-26. PubMed ID: 15029403
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.